Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00467-014-3038-6 http://scihub22266oqcxt.onion/10.1007/s00467-014-3038-6 25986911!ä!25986911 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25986911&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25986911.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Pediatr+Nephrol 2016 ; 31 (2): 217-25 Nephropedia Template TP {{tp|p=25986911|t=2016. Role of therapeutic plasmapheresis in ANCA-associated vasculitis |pdf=|usr=}}{{25986911}} gab.com Text Role of therapeutic plasmapheresis in ANCA-associated vasculitis JO: Pediatr Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25986911 #FOAvip Plasma exchange, or plasmapheresis, is a treatment method that developed over a period of two decades and involves the removal and replacement of a patient's circulating plasma. The aim of treatment is to remove disease-associated molecules and therefore interrupt disease progression. This article summarizes the developmental history of this treatment and then looks in more detail at data on the use of plasma exchange in treating antineutrophil antibody (ANCA)-associated vasculitis. The eight randomized trials and the Cochrane Systematic Review on treating renal vasculitis are summarized to show that plasma exchange may be effective in this disease, specifically in reducing the development of end-stage kidney disease (ESKD) by approximately 40%. The plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS) study is a currently enrolling study aiming to answer some of the outstanding questions relating to the use of this treatment in ANCA-associated vasculitis. Twit Text FOAVip Role of therapeutic plasmapheresis in ANCA-associated vasculitis ????Pediatr Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25986911 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25986911 #FOAvip English Wikipedia <ref>{{Cite pmid|25986911}}</ref> Role of therapeutic plasmapheresis in ANCA-associated vasculitis #MMPMID25986911 Walters G Pediatr Nephrol 2016[Feb]; 31 (2): 217-25 PMID25986911show ga Plasma exchange, or plasmapheresis, is a treatment method that developed over a period of two decades and involves the removal and replacement of a patient's circulating plasma. The aim of treatment is to remove disease-associated molecules and therefore interrupt disease progression. This article summarizes the developmental history of this treatment and then looks in more detail at data on the use of plasma exchange in treating antineutrophil antibody (ANCA)-associated vasculitis. The eight randomized trials and the Cochrane Systematic Review on treating renal vasculitis are summarized to show that plasma exchange may be effective in this disease, specifically in reducing the development of end-stage kidney disease (ESKD) by approximately 40%. The plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS) study is a currently enrolling study aiming to answer some of the outstanding questions relating to the use of this treatment in ANCA-associated vasculitis. |Animals[MESH] |Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/history/*therapy[MESH] |History, 20th Century[MESH] |History, 21st Century[MESH] |Humans[MESH] |Kidney Failure, Chronic/prevention & control[MESH]Role of therapeutic plasmapheresis in ANCA-associated vasculitis (epmc).pdf DeepDyve Pubget Overpricing